Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 4
1992 1
1993 1
1994 1
1995 1
1998 3
2003 1
2004 1
2005 1
2006 1
2007 1
2008 1
2009 1
2012 1
2014 1
2015 1
2016 1
2017 4
2018 2
2019 5
2020 4
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
Lu SC, Chen M, Atangan L, Killion EA, Komorowski R, Cheng Y, Netirojjanakul C, Falsey JR, Stolina M, Dwyer D, Hale C, Stanislaus S, Hager T, Thomas VA, Harrold JM, Lloyd DJ, Véniant MM. Lu SC, et al. Among authors: thomas va. Cell Rep Med. 2021 Apr 30;2(5):100263. doi: 10.1016/j.xcrm.2021.100263. eCollection 2021 May 18. Cell Rep Med. 2021. PMID: 34095876 Free PMC article.
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Véniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA, Ambhaikar M, Sharpsten L, Zhu Y, Kurra V, Jeswani R, Oberoi RK, Parnes JR, Honarpour N, Neutel J, Strande JL. Véniant MM, et al. Among authors: thomas va. Nat Metab. 2024 Feb;6(2):290-303. doi: 10.1038/s42255-023-00966-w. Epub 2024 Feb 5. Nat Metab. 2024. PMID: 38316982 Free PMC article. Clinical Trial.
Hallmarks of neurodegenerative disease: A systems pharmacology perspective.
Bloomingdale P, Karelina T, Ramakrishnan V, Bakshi S, Véronneau-Veilleux F, Moye M, Sekiguchi K, Meno-Tetang G, Mohan A, Maithreye R, Thomas VA, Gibbons F, Cabal A, Bouteiller JM, Geerts H. Bloomingdale P, et al. Among authors: thomas va. CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1399-1429. doi: 10.1002/psp4.12852. Epub 2022 Aug 17. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35894182 Free PMC article. Review.
Chikungunya in a Pediatric Traveler.
Thomas VA, Murray KO, Crouse HL. Thomas VA, et al. Pediatr Emerg Care. 2018 Jul;34(7):e120-e121. doi: 10.1097/PEC.0000000000001457. Pediatr Emerg Care. 2018. PMID: 29596281
Teenager With Scalp Mass.
Thomas VA, Patel B. Thomas VA, et al. Ann Emerg Med. 2017 Mar;69(3):e21-e22. doi: 10.1016/j.annemergmed.2016.10.011. Ann Emerg Med. 2017. PMID: 28231999 No abstract available.
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice.
Liu S, Humphreys SC, Cook KD, Conner KP, Correia AR, Jacobitz AW, Yang M, Primack R, Soto M, Padaki R, Lubomirski M, Smith R, Mock M, Thomas VA. Liu S, et al. Among authors: thomas va. MAbs. 2023 Jan-Dec;15(1):2263926. doi: 10.1080/19420862.2023.2263926. Epub 2023 Oct 12. MAbs. 2023. PMID: 37824334 Free PMC article.
44 results